Bringing the fundamentals into focus…
Back to Arcus Biosciences, Inc.
How Arcus Biosciences, Inc. stacks up
RCUS · against 345 other Healthcare companies of similar size
Growth
8/ 100
Near the bottom of its peers.
Ranked #323 of 346 · scores higher than 6% of peers
Bars: peers in each 10-point band of the growth score26 peers with a growth score of 0–9, including RCUS · Click a bar to see the companies
Why growth scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth, earnings per share growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 96% of peers. Revenue growth: -55.3% vs peer median 6.1%
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- slower revenue growth over three years: weaker than 74% of peers. 3-year revenue growth: -1.1% vs peer median 5.8%
Metric by metric
Position: dot = RCUS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RCUS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 346 reported | -55.3% | 6.9% | 4% | 33% | |
| Earnings per share growthHigher is better · 200 reported | Not reported | 9.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 337 reported | -1.1% | 7.9% | 23% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around RCUS| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 321 | 3.7B USD | 9 | 24 | |
| 323 | 3.7B USD | 8 | 31 | |
| 323 | 2.4B USD | 8 | 27 | |
| 323 | 1.3B USD | 8 | 20 | |
| 323 | 2.4B USD | 8 | 20 | |
| 323 | 3.4B USD | 8 | 55 | |
| 328 | 9.3B CNY (≈$1.3B) | 7 | 32 | |
| 328 | 24.9B CNY (≈$3.5B) | 7 | 38 | |
| 330 | 14.8B CNY (≈$2.1B) | 6 | 23 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score